Rebecca Luse has 17 years of experience in the health care investment business. She joined Deep Track Capital from New Leaf Venture Partners where she worked for six years, most recently as a Principal leading the crossover and public company strategy. She has been a board member and observer for several biotechnology companies. Previously, she spent four years on the sell side at both Jefferies and Piper Jaffray, covering biotechnology and specialty pharmaceuticals companies. She started her career as an investment banking analyst in the health care group of Bank of America and as a venture capital associate at Bay City Capital. She earned a Bachelor of Science in biochemistry and mathematics from Indiana University. She enjoys skiing, traveling, racket sports and board games.
